These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 24570384)

  • 21. Reinterpreting Evidence of Rheumatoid Arthritis-Associated Interstitial Lung Disease to Understand Etiology.
    Wu EK; Ambrosini RD; Kottmann RM; Ritchlin CT; Schwarz EM; Rahimi H
    Curr Rheumatol Rev; 2019; 15(4):277-289. PubMed ID: 30652645
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A Case of Lung Cancer Discovered Due to Unresponsive Course of Corticosteroids for Rheumatoid-Associated Interstitial Lung Disease].
    Oshita H; Ito N; Senoo M; Funaishi K; Mitama Y; Okusaki K
    Gan To Kagaku Ryoho; 2020 Oct; 47(10):1493-1495. PubMed ID: 33130748
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Uncovering risk factors for adverse events and infections in rheumatoid arthritis and rheumatoid arthritis with interstitial lung disease under treatment with biologics or targeted synthetic DMARDs: insights from the KOBIO Registry.
    Kim JW; Shin K; Jung J; Suh CH; Kim J; Lee SK; Kim HA
    Clin Exp Rheumatol; 2024 Sep; 42(9):1781-1791. PubMed ID: 38634363
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interstitial Lung Disease in Elderly Rheumatoid Arthritis Patients.
    Messina R; Guggino G; Benfante A; Scichilone N
    Drugs Aging; 2020 Jan; 37(1):11-18. PubMed ID: 31773418
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Abatacept in patients with rheumatoid arthritis and interstitial lung disease: A national multicenter study of 63 patients.
    Fernández-Díaz C; Loricera J; Castañeda S; López-Mejías R; Ojeda-García C; Olivé A; Rodríguez-Muguruza S; Carreira PE; Pérez-Sandoval T; Retuerto M; Cervantes-Pérez EC; Flores-Robles BJ; Hernández-Cruz B; Urruticoechea A; Maíz-Alonso O; Arboleya L; Bonilla G; Hernández-Rodríguez Í; Palma D; Delgado C; Expósito-Molinero R; Ruibal-Escribano A; Álvarez-Rodríguez B; Blanco-Madrigal J; Bernal JA; Vela-Casasempere P; Rodríguez-Gómez M; Fito C; Ortiz-Sanjuán F; Narváez J; Moreno M; López-Corbeto M; Mena-Vázquez N; Aguilera-Cros C; Romero-Yuste S; Ordóñez S; Villa-Blanco I; Gonzélez-Vela MC; Mora-Cuesta V; Palmou-Fontana N; Hernández JL; González-Gay MA; Blanco R
    Semin Arthritis Rheum; 2018 Aug; 48(1):22-27. PubMed ID: 29422324
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of abatacept in interstitial lung disease of rheumatoid arthritis: A systematic literature review.
    Vicente-Rabaneda EF; Atienza-Mateo B; Blanco R; Cavagna L; Ancochea J; Castañeda S; González-Gay MÁ
    Autoimmun Rev; 2021 Jun; 20(6):102830. PubMed ID: 33887489
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interstitial lung disease in rheumatoid arthritis.
    Ascherman DP
    Curr Rheumatol Rep; 2010 Oct; 12(5):363-9. PubMed ID: 20628839
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Design and Rationale of the Trail1 Trial: A Randomized Double-Blind Phase 2 Clinical Trial of Pirfenidone in Rheumatoid Arthritis-Associated Interstitial Lung Disease.
    Solomon JJ; Danoff SK; Goldberg HJ; Woodhead F; Kolb M; Chambers DC; DiFranco D; Spino C; Haynes-Harp S; Hurwitz S; Peters EB; Dellaripa PF; Rosas IO;
    Adv Ther; 2019 Nov; 36(11):3279-3287. PubMed ID: 31515704
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A retrospective study on the predictive implications of clinical characteristics and therapeutic management in patients with rheumatoid arthritis-associated interstitial lung disease.
    Li L; Liu R; Zhang Y; Zhou J; Li Y; Xu Y; Gao S; Zheng Y
    Clin Rheumatol; 2020 May; 39(5):1457-1470. PubMed ID: 31858341
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Rheumatoid arthritis and lung - more than a minor aspect of the disease].
    Fiehn C
    Dtsch Med Wochenschr; 2015 Jun; 140(12):904-7. PubMed ID: 26069917
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-anti-TNF biologic agents are associated with slower worsening of interstitial lung disease secondary to rheumatoid arthritis.
    Mena-Vázquez N; Godoy-Navarrete FJ; Manrique-Arija S; Aguilar-Hurtado MC; Romero-Barco CM; Ureña-Garnica I; Espildora F; Añón-Oñate I; Pérez-Albaladejo L; Gomez-Cano C; Jimenez-Núñez FG; Padin-Martín MI; Fernández-Nebro A
    Clin Rheumatol; 2021 Jan; 40(1):133-142. PubMed ID: 32557255
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Methotrexate and rheumatoid arthritis associated interstitial lung disease.
    Juge PA; Lee JS; Lau J; Kawano-Dourado L; Rojas Serrano J; Sebastiani M; Koduri G; Matteson E; Bonfiglioli K; Sawamura M; Kairalla R; Cavagna L; Bozzalla Cassione E; Manfredi A; Mejia M; Rodríguez-Henriquez P; González-Pérez MI; Falfán-Valencia R; Buendia-Roldán I; Pérez-Rubio G; Ebstein E; Gazal S; Borie R; Ottaviani S; Kannengiesser C; Wallaert B; Uzunhan Y; Nunes H; Valeyre D; Saidenberg-Kermanac'h N; Boissier MC; Wemeau-Stervinou L; Flipo RM; Marchand-Adam S; Richette P; Allanore Y; Dromer C; Truchetet ME; Richez C; Schaeverbeke T; Lioté H; Thabut G; Deane KD; Solomon JJ; Doyle T; Ryu JH; Rosas I; Holers VM; Boileau C; Debray MP; Porcher R; Schwartz DA; Vassallo R; Crestani B; Dieudé P
    Eur Respir J; 2021 Feb; 57(2):. PubMed ID: 32646919
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The multifaceted aspects of interstitial lung disease in rheumatoid arthritis.
    Cavagna L; Monti S; Grosso V; Boffini N; Scorletti E; Crepaldi G; Caporali R
    Biomed Res Int; 2013; 2013():759760. PubMed ID: 24205507
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rheumatoid arthritis-associated interstitial lung disease: an overview of epidemiology, pathogenesis and management.
    Dai Y; Wang W; Yu Y; Hu S
    Clin Rheumatol; 2021 Apr; 40(4):1211-1220. PubMed ID: 32794076
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of rituximab on the progression of rheumatoid arthritis-related interstitial lung disease: 10 years' experience at a single centre.
    Md Yusof MY; Kabia A; Darby M; Lettieri G; Beirne P; Vital EM; Dass S; Emery P
    Rheumatology (Oxford); 2017 Aug; 56(8):1348-1357. PubMed ID: 28444364
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Updates on interstitial lung disease and other selected extra-articular manifestations of rheumatoid arthritis.
    Myasoedova E; Matteson EL
    Curr Opin Rheumatol; 2024 May; 36(3):203-208. PubMed ID: 38411210
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The interplay between rheumatic diseases and pulmonary health.
    Fedorchenko Y; Zimba O; Yatsyshyn R; Doskaliuk B; Zaiats L; Fedorchenko M
    Rheumatol Int; 2024 Jul; 44(7):1179-1184. PubMed ID: 38509351
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk of serious infection in patients with rheumatoid arthritis-associated interstitial lung disease.
    Zamora-Legoff JA; Krause ML; Crowson CS; Ryu JH; Matteson EL
    Clin Rheumatol; 2016 Oct; 35(10):2585-9. PubMed ID: 27448151
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rheumatoid arthritis extra-articular lung disease: new insights on pathogenesis and experimental drugs.
    Sebastiani M; Manfredi A; Croci S; Faverio P; Cassone G; Vacchi C; Salvarani C; Luppi F
    Expert Opin Investig Drugs; 2024 Aug; 33(8):815-827. PubMed ID: 38967534
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rheumatoid arthritis and lung disease: from mechanisms to a practical approach.
    Lake F; Proudman S
    Semin Respir Crit Care Med; 2014 Apr; 35(2):222-38. PubMed ID: 24668537
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.